Add Company
Join Now

NeuBase Therapeutics Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • NeuBase Therapeutics's estimated annual revenue is currently $6.8M per year.(i)
  • NeuBase Therapeutics's estimated revenue per employee is $201,000

Employee Data

  • NeuBase Therapeutics has 34 Employees.(i)
  • NeuBase Therapeutics grew their employee count by -32% last year.

NeuBase Therapeutics's People

NameTitleEmail/Phone
1
Chief People OfficerReveal Email/Phone
2
Chief Financial OfficerReveal Email/Phone
3
VP ResearchReveal Email/Phone
4
President and COOReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$46.6M2328%N/AN/A
#2
$84.2M4193%N/AN/A
#3
$14.1M700%N/AN/A
#4
$1224.3M6091-9%N/AN/A
#5
$43.2M215-4%N/AN/A
#6
$12.3M61-6%N/AN/A
#7
$19.9M9941%N/AN/A
#8
$16.5M82-5%N/AN/A
#9
$97.7M48630%N/AN/A
#10
$12.5M62-16%N/AN/A
Add Company

What Is NeuBase Therapeutics?

NeuBase has developed a modular antisense technology platform with the capability to address any rare genetic disease caused by mutant proteins with a single, cohesive approach. NeuBase's platform improves upon gene silencing therapies by combining the advantages of synthetic approaches with the precision of antisense technologies. NeuBase plans to use its unparalleled antisense platform to address both repeat expansion disorders, with an initial focus on Huntington's Disease and Myotonic Dystrophy, and dominant genetic disorders.

keywords:N/A

N/A

Total Funding

34

Number of Employees

$6.8M

Revenue (est)

-32%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$6.8M3410%N/A
#2
$7.9M34-3%N/A
#3
$6.7M343%N/A
#4
$3.5M3417%N/A
#5
$8.5M346%N/A